Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward V Loftus

Showing results (281-290 of 471) with videos related to

Pageof 48
Sort By:
Journal of Crohn'S & Colitis|April 29, 2014
Neoplasia in the ileoanal pouch following colectomy in patients with ulcerative colitis and primary sclerosing cholangitisMohamad H Imam, John E Eaton, Jason S Puckett, et al.
Journal of Crohn'S & Colitis|August 21, 2016
Postoperative Outcomes in Vedolizumab-Treated Patients Undergoing Abdominal Operations for Inflammatory Bowel DiseaseAmy L Lightner, Laura E Raffals, Kellie L Mathis, et al.
Digestive Diseases and Sciences|December 19, 2025
Evaluating the Impact of Visceral Adiposity and Sarcopenia on Outcomes in Hospitalized Patients with Acute Severe Ulcerative ColitisPrajith Raj Ramesh, Robert P Hartman, William S Harmsen, et al.
Gastroenterology|January 10, 2002
Epstein-Barr virus-positive lymphoma in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurineGerald A Dayharsh, Edward V Loftus, William J Sandborn, et al.
Inflammatory Bowel Diseases|February 13, 2019
Adalimumab Effectiveness Up to Six Years in Adalimumab-naïve Patients with Crohn's Disease: Results of the PYRAMID RegistryEdward V Loftus, Walter Reinisch, Remo Panaccione, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 28, 2010
Perioperative anti-tumor necrosis factor therapy does not increase the rate of early postoperative complications in Crohn's diseaseBasil S Nasir, Eric J Dozois, Robert R Cima, et al.
Gut|January 22, 2013
Geographical variability and environmental risk factors in inflammatory bowel diseaseSiew C Ng, Charles N Bernstein, Morten H Vatn, et al.
Inflammatory Bowel Diseases|May 11, 2013
Cumulative incidence and risk factors for hospitalization and surgery in a population-based cohort of ulcerative colitisSunil Samuel, Steven B Ingle, Shamina Dhillon, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 3, 2021
The Epidemiology of Microscopic Colitis in Olmsted County, Minnesota: Population-Based Study From 2011 to 2019June Tome, Kanika Sehgal, Amrit K Kamboj, et al.
Advances in Therapy|November 28, 2025
One Subcutaneous 2-ml Injection of Mirikizumab is Bioequivalent to Two 1-ml Subcutaneous Injections in Healthy ParticipantsYuki Otani, Christopher D Payne, Edward V Loftus, et al.
Pageof 48

Showing results (281-290 of 471) with videos related to

Sort By:
Pageof 48
Journal of Crohn'S & Colitis|April 29, 2014
Neoplasia in the ileoanal pouch following colectomy in patients with ulcerative colitis and primary sclerosing cholangitisMohamad H Imam, John E Eaton, Jason S Puckett, et al.
Journal of Crohn'S & Colitis|August 21, 2016
Postoperative Outcomes in Vedolizumab-Treated Patients Undergoing Abdominal Operations for Inflammatory Bowel DiseaseAmy L Lightner, Laura E Raffals, Kellie L Mathis, et al.
Digestive Diseases and Sciences|December 19, 2025
Evaluating the Impact of Visceral Adiposity and Sarcopenia on Outcomes in Hospitalized Patients with Acute Severe Ulcerative ColitisPrajith Raj Ramesh, Robert P Hartman, William S Harmsen, et al.
Gastroenterology|January 10, 2002
Epstein-Barr virus-positive lymphoma in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurineGerald A Dayharsh, Edward V Loftus, William J Sandborn, et al.
Inflammatory Bowel Diseases|February 13, 2019
Adalimumab Effectiveness Up to Six Years in Adalimumab-naïve Patients with Crohn's Disease: Results of the PYRAMID RegistryEdward V Loftus, Walter Reinisch, Remo Panaccione, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 28, 2010
Perioperative anti-tumor necrosis factor therapy does not increase the rate of early postoperative complications in Crohn's diseaseBasil S Nasir, Eric J Dozois, Robert R Cima, et al.
Gut|January 22, 2013
Geographical variability and environmental risk factors in inflammatory bowel diseaseSiew C Ng, Charles N Bernstein, Morten H Vatn, et al.
Inflammatory Bowel Diseases|May 11, 2013
Cumulative incidence and risk factors for hospitalization and surgery in a population-based cohort of ulcerative colitisSunil Samuel, Steven B Ingle, Shamina Dhillon, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 3, 2021
The Epidemiology of Microscopic Colitis in Olmsted County, Minnesota: Population-Based Study From 2011 to 2019June Tome, Kanika Sehgal, Amrit K Kamboj, et al.
Advances in Therapy|November 28, 2025
One Subcutaneous 2-ml Injection of Mirikizumab is Bioequivalent to Two 1-ml Subcutaneous Injections in Healthy ParticipantsYuki Otani, Christopher D Payne, Edward V Loftus, et al.
Pageof 48